Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Qiagen N.V. (QGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,442,581
  • Shares Outstanding, K 228,230
  • Annual Sales, $ 1,338 M
  • Annual Income, $ 80,400 K
  • 36-Month Beta 1.10
  • Price/Sales 5.32
  • Price/Cash Flow 15.11
  • Price/Book 2.90

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.78 +7.29%
on 01/02/18
33.03 -0.02%
on 01/17/18
+0.91 (+2.82%)
since 12/15/17
3-Month
30.20 +9.35%
on 11/07/17
34.56 -4.44%
on 10/18/17
-1.23 (-3.60%)
since 10/17/17
52-Week
27.51 +20.05%
on 01/25/17
36.34 -9.12%
on 10/11/17
+4.27 (+14.85%)
since 01/17/17

Most Recent Stories

More News
HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced it has entered into a third statement of work...

HTGM : 2.91 (-16.86%)
QGEN : 33.02 (+1.26%)
QIAGEN Partners DiaSorin, Boosts Molecular Diagnostics Arm

QIAGEN (QGEN) continues to adopt initiatives to strengthen Molecular Diagnostics business.

AMED : 56.21 (-1.44%)
BIO : 253.09 (+1.60%)
QGEN : 33.02 (+1.26%)
ISRG : 431.49 (+2.72%)
Abbott Boosts Diagnostics Arm With Alinity H-Series Launch

Abbott (ABT) adopts initiatives to strengthen hold in the high-potential diagnostics market.

ABT : 58.98 (+0.92%)
DGX : 101.43 (+0.21%)
WBA : 75.96 (-0.09%)
QGEN : 33.02 (+1.26%)
Watch for Qiagen Nv to Potentially Rebound After Falling 1.05% Yesterday

Qiagen Nv (NASDAQ:QGEN) traded in a range yesterday that spanned from a low of $31.00 to a high of $31.25. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $31.06...

QGEN : 33.02 (+1.26%)
SmarTrend Watching for Potential Rebound in Shares of Qiagen Nv After 1.05% Loss

Qiagen Nv (NASDAQ:QGEN) traded in a range yesterday that spanned from a low of $31.00 to a high of $31.25. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $31.06...

QGEN : 33.02 (+1.26%)
Qiagen Nv is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (QGEN, ILMN, TMO, INCR, A )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

ILMN : 242.59 (+0.48%)
INCR : 40.50 (-1.94%)
TMO : 211.24 (+1.55%)
QGEN : 33.02 (+1.26%)
QIAGEN to Take Impairment on Deferred Tax Assets, Informs on Expected Impacts of New U.S. Tax Law and Other Changes in Global Tax Environment

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announces that, mainly as a consequence of the new U.S. tax legislation, it will take an after-tax charge on net income of approximately $110-120...

QGEN : 33.02 (+1.26%)
QIAGEN and Oxford Immunotec Settle Patent Infringement Lawsuit

QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) and Oxford Immunotec Ltd. (NASDAQ: OXFD) announced today that they have reached a settlement in the lawsuit in the U.S. District Court for the...

OXFD : 11.60 (-0.34%)
QGEN : 33.02 (+1.26%)
QIAGEN Advances Precision Medicine by Automating Guidelines on Cancer Variants in Industry-leading QIAGEN Clinical Insight Software

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for...

QGEN : 33.02 (+1.26%)
QIAGEN's GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology

QIAGEN N.V. (NASDAQ: QGEN) (Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world's first...

QGEN : 33.02 (+1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.

See More

Key Turning Points

2nd Resistance Point 33.10
1st Resistance Point 32.85
Last Price 33.02
1st Support Level 32.46
2nd Support Level 32.31

See More

52-Week High 36.34
Last Price 33.02
Fibonacci 61.8% 32.97
Fibonacci 50% 31.92
Fibonacci 38.2% 30.88
52-Week Low 27.51

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.